ORBIMED ADVISORS LLC
10% Owner; Director; Director, 10% Owner · 21 filings · Latest: Sep 28, 2026
ADARx Pharmaceuticals, Inc.
Adicet Bio, Inc.
BlossomHill Therapeutics, Inc.
Braveheart Bio, Inc.
Electra Therapeutics, Inc.
Enliven Therapeutics, Inc.
ImageneBio, Inc.
Prelude Therapeutics Inc
Q32 Bio Inc.
Scribe Therapeutics, Inc.
Shattuck Labs, Inc.
Sionna Therapeutics, Inc.
Traws Pharma, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
TRAW | ORBIMED ADVISORS LLC | 10% Owner | Apr 16, 2026 | Purchase | $1.67 | 597,729 | $998.2K | 1,203,250 | |
PRLD | ORBIMED ADVISORS LLC | Director, 10% Owner | Apr 21, 2026 | Purchase | $4.44 | 2,815,315 | $12.5M | 1,126,126 | |
SION | ORBIMED ADVISORS LLC | Director | Apr 18, 2026 | Sale | $44.52 | 2,948 | $131.2K | 2,964,774 | |
SION | ORBIMED ADVISORS LLC | Director | Apr 17, 2026 | Sale | $44.68 | 52,397 | $2.3M | 2,967,722 | |
SION | ORBIMED ADVISORS LLC | Director | Apr 16, 2026 | Sale | $45.34 | 226,906 | $10.3M | 3,020,119 | |
SION | ORBIMED ADVISORS LLC | Director | Apr 15, 2026 | Sale | $44.64 | 235,863 | $10.5M | 3,247,025 | |
SION | ORBIMED ADVISORS LLC | Director | Apr 14, 2026 | Sale | $44.51 | 47,814 | $2.1M | 3,482,888 | |
ACET | ORBIMED ADVISORS LLC | 10% Owner | Apr 8, 2026 | Sale | $6.42 | 72,939 | $468.1K | 0 | |
ACET | ORBIMED ADVISORS LLC | 10% Owner | Apr 7, 2026 | Sale | $6.52 | 31,719 | $206.8K | 32,523 | |
ACET | OrbiMed Genesis Master Fund, L.P. | — | Apr 9, 2026 | Proposed Sale | $6.55 | 78,499 | $514.2K | — | |
KROS | OrbiMed Genesis Master Fund, LP | — | Mar 31, 2026 | Proposed Sale | $11.04 | 45,057 | $497.4K | — | |
SION | ORBIMED ADVISORS LLC | Director | Feb 3, 2026 | Sale | $44.58 | 29,063 | $1.3M | 3,530,702 | |
SION | ORBIMED ADVISORS LLC | Director | Feb 2, 2026 | Sale | $44.57 | 1,890 | $84.2K | 3,559,765 | |
SION | OrbiMed Private Investments VIII, LP | — | Nov 24, 2025 | Proposed Sale | $44.38 | 1,047,770 | $46.5M | — | |
PMVP | OrbiMed Private Investments V, LP | — | Oct 23, 2025 | Proposed Sale | $1.52 | 1,000,000 | $1.5M | — | |
IRON | OrbiMed Private Investments VI, LP | — | Oct 20, 2025 | Proposed Sale | $89.94 | 482,308 | $43.4M | — | |
IRON | OrbiMed Genesis Master Fund, L.P. | — | Oct 20, 2025 | Proposed Sale | $89.94 | 186,541 | $16.8M | — | |
IRON | OrbiMed Private Investments VIII, LP | — | Oct 20, 2025 | Proposed Sale | $89.94 | 746,171 | $67.1M | — | |
PMVP | OrbiMed Private Investments V, LP | — | Sep 10, 2025 | Proposed Sale | $1.60 | 2,283,654 | $3.7M | — | |
PASG | OrbiMed Private Investments VII, LP | — | Jul 21, 2025 | Proposed Sale | $5.56 | 132,645 | $737.5K | — |